Generali Investments CEE’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$854K Hold
20,000
0.04% 311
2026
Q1
$1.25M Hold
20,000
0.07% 260
2025
Q4
$1.91M Hold
20,000
0.13% 185
2025
Q3
$1.95M Hold
20,000
0.15% 173
2025
Q2
$2.15M Hold
20,000
0.18% 160
2025
Q1
$2.02M Hold
20,000
0.19% 157
2024
Q4
$1.79M Buy
+20,000
New +$1.76M 0.18% 154

Other funds holding BSX

Generali Investments CEE's BSX Position: Q2 2026 in Review

Generali Investments CEE held its Boston Scientific (BSX) position steady in Q2 2026 at 20,000 shares worth $854K. The position accounts for 0.04% of the portfolio, ranked #311.

Generali Investments CEE first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.15M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Generali Investments CEE held 20,000 shares of Boston Scientific worth $854K as of Q2 2026.
  • Generali Investments CEE left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.04% of Generali Investments CEE's portfolio in Q2 2026, its #311 holding.
  • Generali Investments CEE first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • Generali Investments CEE's Boston Scientific position peaked at $2.15M in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.